Sign in to view content

Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen

Michael J Allingham, MD, PhD

Video
Published 2019

Michael J. Allingham, MD, PhD

AMD Non-neovscular Symposium

Related

Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
Annual Meeting Talks
2020
Clinical Trials Handbook
Nikolas JS London, MD, FACS, FASRS
Updates from the Field
2021
Dual Anti-platelet Therapy Decelerates the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Yodpong Chantarasorn, MD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more